Patent · US Active

Diazepinoes

US7943608B2 · kind B2 · utility

42Cited by

2References

7Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Melanie Schultz · Darmstadt, DE
Lars Burgdorf · Frankfurt am Main, DE
Dirk Finsinger · Darmstadt, DE
Andree Blaukat · Heilbad Heiligenstadt, DE
Hartmut Greiner · Darmstadt, DE
Christina Esdar · Darmstadt, DE

Key dates

Filing date	Nov 28, 2006
Grant date	May 17, 2011
Priority date	—
Expiry date	Nov 10, 2027

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to compounds of the formula (I), to the preparation and use thereof for the preparation of a medicament for the treatment of diseases, in particular tumours and/or diseases in the development or course of which kinases are involved.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.